Eric Dessertenne
Chief Executive Officer presso BIOCORP
Profilo
Eric Dessertenne is currently the Chief Executive Officer at BIOCORP Production SA since 2019.
He is also the Chairman at Aagie Sas and the Manager at Groupement foncier agricole René PATOU.
Previously, he served as the Chief Executive Officer at Brenus Pharma SAS.
Dr. Dessertenne holds an MBA from ESSEC Business School and an undergraduate degree from Université Blaise Pascal.
Posizioni attive di Eric Dessertenne
Società | Posizione | Inizio |
---|---|---|
BIOCORP | Chief Executive Officer | 23/12/2019 |
Groupement foncier agricole René PATOU | Corporate Officer/Principal | - |
Aagie Sas | Chairman | - |
Precedenti posizioni note di Eric Dessertenne
Società | Posizione | Fine |
---|---|---|
Brenus Pharma SAS
Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti. | Chief Executive Officer | - |
Formazione di Eric Dessertenne
ESSEC Business School | Masters Business Admin |
Université Blaise Pascal | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIOCORP | Health Technology |
Aziende private | 3 |
---|---|
Brenus Pharma SAS
Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti. | Commercial Services |
Groupement foncier agricole René PATOU | |
Aagie Sas |
- Borsa valori
- Insiders
- Eric Dessertenne